Grifols (GIFLF) Shares Outstanding (Entity) (2009 - 2025)
Powered by 
Analysis
Grifols (GIFLF) Shares Outstanding (Entity) (2009 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 540.60 Mn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | 253.35 Mn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 102.80 Mn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | 399.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | 147.75 Mn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | 722.67 Mn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | 680.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 680.51 Mn |
| Dec 31, 2024 | 679.67 Mn |
| Dec 31, 2023 | 679.76 Mn |
| Dec 31, 2022 | 679.81 Mn |
| Dec 31, 2021 | 681.56 Mn |
| Dec 31, 2020 | 685.52 Mn |
| Dec 31, 2019 | 685.12 Mn |
| Dec 31, 2018 | 684.71 Mn |
| Dec 31, 2017 | 684.20 Mn |
| Dec 31, 2016 | 683.23 Mn |
| Dec 31, 2015 | 683.55 Mn |
| Dec 31, 2014 | 685.34 Mn |
| Dec 31, 2013 | 681.01 Mn |
| Dec 31, 2012 | 342.70 Mn |
| Dec 31, 2011 | 616.07 Mn |
| Dec 31, 2010 | 517.80 Mn |
| Dec 31, 2009 | 510.89 Mn |